当前位置:首页 - 行情中心 - 盘龙药业(002864) - 财务分析

盘龙药业

(002864)

  

流通市值:22.65亿  总市值:32.45亿
流通股本:7419.07万   总股本:1.06亿

盘龙药业(002864)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.90亿元,每股收益0.85元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益168571.85万元,未分配利润70774.27万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产240103.25万元,负债71531.40万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入841,452,392.85574,023,000.14250,212,341.68973,864,163.02
营业总成本735,238,373.82502,134,108.31213,738,632.71843,758,147.88
其他经营收益
营业利润107,939,366.8770,662,996.836,225,272.1138,367,014.5
利润总额106,709,241.370,061,376.5336,219,184.36136,951,823.62
净利润89,602,427.8659,979,473.5131,165,841.97119,924,689.91
每股收益
其他综合收益----
综合收益总额89,602,427.8659,979,473.5131,165,841.97119,924,689.91
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,876,878,524.251,855,373,268.191,809,097,800.41,771,523,291.39
非流动资产:
非流动资产合计524,153,995.45506,873,226.32507,095,597.03508,499,718.15
资产总计2,401,032,519.72,362,246,494.512,316,193,397.432,280,023,009.54
流动负债:
流动负债合计603,981,692.81485,824,666.12456,360,474.14446,110,297.49
非流动负债:
非流动负债合计111,332,341.66210,175,675.31196,409,174.58196,729,957.59
负债合计715,314,034.47696,000,341.43652,769,648.72642,840,255.08
所有者权益(或股东权益):
归属于母公司股东权益合计1,683,956,206.541,664,436,104.931,661,541,455.771,635,217,029.35
股东权益合计1,685,718,485.231,666,246,153.081,663,423,748.711,637,182,754.46
负债和股东权益合计2,401,032,519.72,362,246,494.512,316,193,397.432,280,023,009.54
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计907,591,251.68590,274,865.63281,363,514.111,090,465,347.97
经营活动现金流出小计818,435,303.35527,653,966.61255,398,787.99933,872,525.21
经营活动产生的现金流量净额89,155,948.3362,620,899.0225,964,726.12156,592,822.76
投资活动产生的现金流量:
投资活动现金流入小计283,204.171,769.91-2,032,209.71
投资活动现金流出小计48,091,241.4331,076,298.3822,733,672.35105,539,824.42
投资活动产生的现金流量净额-47,808,037.26-31,074,528.47-22,733,672.35-103,507,614.71
筹资活动产生的现金流量:
筹资活动现金流入小计50,000,00050,000,00050,000,000150,000,000
筹资活动现金流出小计96,093,434.6384,155,589.1756,907,331.39135,722,871.15
筹资活动产生的现金流量净额-46,093,434.63-34,155,589.17-6,907,331.3914,277,128.85
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-4,745,523.56-2,609,218.62-3,676,277.6267,362,336.9
期末现金及现金等价物余额1,164,629,665.61,166,765,970.541,165,698,911.541,169,375,189.16
补充资料:
现金及现金等价物的净增加额--2,609,218.62-67,362,336.9
最新报告期:2025-09-03
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券刘鹏,蔡航1.171.351.592025-09-03
TOP↑